Slow-release oral morphine as opioid agonist therapy: Plain language summary

Evidence, Guidelines and Recommendations

A summary of the recommendations, intended for patients interested in learning about SROM as OAT.

Details

Category
Evidence, Guidelines and Recommendations
Format
PDF Document
File Size
0.09 MB
Downloads
3
Added
Aug 25, 2025
Tags
Psychiatry
Pain
Mental Health
Substance Use Disorders
Primary Care
Internal Medicine
Emergency Medicine

Related Resources

Recommendations for the use of slow-release oral morphine as opioid agonist therapy
Bringing together published evidence and both clinical and experiential expertise, these recommendations are intended to guide prescribers in the use of slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT).